Identification of P2Y receptors involved in oleamide-suppressing inflammatory responses in murine microglia and human dendritic cells

[1]  Beth Stevens,et al.  Microglia emerge as central players in brain disease , 2017, Nature Medicine.

[2]  J. Salazar,et al.  The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma , 2017, Front. Aging Neurosci..

[3]  Kenji F. Tanaka,et al.  Transformation of Astrocytes to a Neuroprotective Phenotype by Microglia via P2Y1 Receptor Downregulation. , 2017, Cell reports.

[4]  J. Ávila,et al.  Alzheimer’s disease as an inflammatory disease , 2017, Biomolecular concepts.

[5]  K. Kaibuchi,et al.  Phospholipid localization implies microglial morphology and function via Cdc42 in vitro , 2017, Glia.

[6]  K. Mackie,et al.  Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[7]  B. Kornum,et al.  A critical look at the function of the P2Y11 receptor , 2016, Purinergic Signalling.

[8]  J. Aoki,et al.  Conformational Constraint of the Glycerol Moiety of Lysophosphatidylserine Affords Compounds with Receptor Subtype Selectivity. , 2016, Journal of medicinal chemistry.

[9]  S. J. Guzman,et al.  P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction , 2016, Neural plasticity.

[10]  Xia Zhang,et al.  Role of neuroinflammation in neurodegenerative diseases (Review) , 2016, Molecular medicine reports.

[11]  D. Babuty,et al.  Hypoxia/Reoxygenation Inhibits P2Y11 Receptor Expression and Its Immunosuppressive Activity in Human Dendritic Cells , 2015, The Journal of Immunology.

[12]  H. Nakayama,et al.  Preventive Effects of a Fermented Dairy Product against Alzheimer’s Disease and Identification of a Novel Oleamide with Enhanced Microglial Phagocytosis and Anti-Inflammatory Activity , 2015, PloS one.

[13]  J. Aoki,et al.  Lysophosphatidylserine analogues differentially activate three LysoPS receptors. , 2015, Journal of biochemistry.

[14]  B. Fiebich,et al.  The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain , 2014, Front. Cell. Neurosci..

[15]  G. Olmos,et al.  Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity , 2014, Mediators of inflammation.

[16]  R. Cunha,et al.  ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice , 2014, The European journal of neuroscience.

[17]  Alex R. B. Thomsen,et al.  Delineation of the GPRC6A Receptor Signaling Pathways Using a Mammalian Cell Line Stably Expressing the Receptor , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[18]  S. Duan,et al.  P2Y4 Receptor-Mediated Pinocytosis Contributes to Amyloid Beta-Induced Self-Uptake by Microglia , 2013, Molecular and Cellular Biology.

[19]  J. Lechleiter,et al.  P2Y1R-Initiated, IP3R-Dependent Stimulation of Astrocyte Mitochondrial Metabolism Reduces and Partially Reverses Ischemic Neuronal Damage in Mouse , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  S. Higashiyama,et al.  TGFα shedding assay: an accurate and versatile method for detecting GPCR activation , 2012, Nature Methods.

[21]  K. Varani,et al.  Retracted: Cannabinoid CB2 receptors modulate ERK‐1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide , 2012, British journal of pharmacology.

[22]  H. Tozaki-Saitoh,et al.  Astrocytic P2Y1 receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  M. Svensson,et al.  Dendritic Cell Regulation by Cannabinoid-Based Drugs , 2010, Pharmaceuticals.

[24]  I. Kang,et al.  Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-κB activation in BV2 murine microglial cells , 2010, Neuroscience Letters.

[25]  G. Schmalzing,et al.  NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells , 2010, Journal of Pharmacology and Experimental Therapeutics.

[26]  H. Tozaki-Saitoh,et al.  P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL‐6 release in hippocampal cultures , 2009, Glia.

[27]  M. Glass,et al.  The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. , 2007, Current neuropharmacology.

[28]  K. Jacobson,et al.  UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.

[29]  G. Velasco,et al.  Cannabinoid CB2 receptor: a new target for controlling neural cell survival? , 2007, Trends in pharmacological sciences.

[30]  R. Nitsch,et al.  The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.

[31]  M. L. de Ceballos,et al.  Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation , 2005, The Journal of Neuroscience.

[32]  K. Jacobson,et al.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.

[33]  D. Kendall,et al.  Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors , 2004, British journal of pharmacology.

[34]  Haruyasu Yamamoto,et al.  Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors , 2003, Brain Research.

[35]  C. Boucsein,et al.  Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro , 2003, The European journal of neuroscience.

[36]  E. Del Giudice,et al.  Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide , 2003, Glia.

[37]  M. Satoh,et al.  Expression of inducible nitric oxide synthase mRNA and production of nitric oxide are induced by adenosine triphosphate in cultured rat microglia , 2000, Neuroscience Letters.

[38]  Kazuhide Inoue,et al.  Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia , 2000 .

[39]  F. Virgilio,et al.  Kinetics and Mechanism of ATP-Dependent IL-1β Release from Microglial Cells1 , 2000, The Journal of Immunology.

[40]  G. Cabral,et al.  Cannabinoids inhibit LPS‐inducible cytokine mRNA expression in rat microglial cells , 2000, Glia.

[41]  F. Di Virgilio,et al.  Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. , 2000, Journal of immunology.

[42]  J. T. Turner,et al.  PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptors , 1996, British journal of pharmacology.

[43]  R. Lerner,et al.  Chemical characterization of a family of brain lipids that induce sleep. , 1995, Science.